supplementary material

[키워드] 1:1 48 hours adverse event allocation approved ARMS attending physician authors Blinding Care Caregiver Caregivers Child chronic Chronic kidney disease Chronic respiratory failure Composite computer consent form Control Corticosteroids COVID-19 COVID-19 pneumonia cumulative incidence Date Day decrease defined delirium Deterioration dissemination early treatment Efficacy element emergency room evaluate exclusion criteria FiO2 glycemic GRADE grade 3 hospital ICU inclusion criteria Infection infections insulin intensive care interruption Intervention invasive Invasive mechanical ventilation investigator Kidney disease Liver damage Mechanical mechanical ventilation minute nasal nasal cannula not blinded number objective on mechanical ventilation outcome oxygen Oxygen requirements participant Participation Patient patients patients with COVID-19 PCR Pneumonia Pragmatic pragmatic clinical trial Prednisone Pregnancy Primary outcome principal investigator progression protocol random randomised randomised controlled trial Randomized registration number Requirement respiratory Respiratory failure responsibility RT-PCR Sample size secondary Serious Adverse Event Serious Adverse Events Stata statistician status steroid Study protocol submitted supplementary material time Treatment Trial Trial registration urinary tract infection use of corticosteroid usual care venturi mask was used website with COVID-19
[DOI] 10.1186/s13063-021-05046-6 PMC 바로가기 [Article Type] Letter